Jiksak Bioengineering

Jamaica
Moneague, Saint Ann Parish, Jamaica, 212-0032

Company profile

Jiksak Bioengineering company profile

Jiksak Bioengineering is a biotechnology company. Jiksak Bioengineering provide an efficient screening service using a three-dimensional cell tissue "Nerve Organoid". We will mainly develop screening technologies specifically for neurodegenerative diseases and search for drugs that are effective for amyotrophic lateral sclerosis (ALS).

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$1M-$10M
Founded
2017-02-07

Headquarters

Postal code
212-0032
Country code
JM
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$1.6M
Last funding
Series B / 2021-03-23
Last equity funding
Series B
Investors
6
Lead investors
2
Founders
2
Articles
6

Founders and investors

Founders

Haruyoshi KawadaNorihiro Yumoto

Lead investors

CEJ CapitalCyberdyne

Investors

ANRICEJ CapitalCyberdyneEssential PharmaOhara Pharmaceutical